Raras
Buscar doenças, sintomas, genes...
Alteração do metabolismo do cobre
ORPHA:309839CID-10 · E83.0CID-11 · 5C64.0DOENÇA RARA

É uma doença metabólica genética que acontece por causa de um problema no controle do cobre dentro das células.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença metabólica genética que acontece por causa de um problema no controle do cobre dentro das células.

Publicações científicas
424 artigos
Último publicado: 2026 Apr 4
Medicamentos
3 registrados
CELECOXIB, BUPROPION HYDROCHLORIDE, BUPROPION

Tem tratamento?

3 medicamentos registrados
Ver detalhes, fases e interações →
CELECOXIBBUPROPION HYDROCHLORIDEBUPROPION
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, SC, RS, ES +8CID-10: E83.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010538
Dosagem de ceruloplasmina (Wilson)lab_test
0202010562
Dosagem de cobre sérico
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
35 sintomas
🦴
Ossos e articulações
28 sintomas
🧠
Neurológico
25 sintomas
🧬
Pele e cabelo
18 sintomas
😀
Face
14 sintomas
💪
Músculos
9 sintomas

+ 120 sintomas em outras categorias

Características mais comuns

Pescoço longo
Polineuropatia mista desmielinizante e axonal
Baixa estatura
Distensão abdominal
Coxa valga
Fadiga
281sintomas
Sem dados (281)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 281 características clínicas mais associadas, ordenadas por frequência.

Pescoço longoLong neck
Polineuropatia mista desmielinizante e axonalMixed demyelinating and axonal polyneuropathy
Baixa estaturaShort stature
Distensão abdominalAbdominal distention
Coxa valga

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico424PubMed
Últimos 10 anos199publicações
Pico202227 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição.

AP1S1AP-1 complex subunit sigma-1ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle membraneMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

MEDNIK syndrome

A disorder characterized by erythematous skin lesions and hyperkeratosis, severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss, together with elevated very-long-chain fatty acids and severe congenital diarrhea.

OUTRAS DOENÇAS (1)
MEDNIK syndrome
HGNC:559UniProt:P61966
ATP7ACopper-transporting ATPase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneCell membraneMelanosome membraneEarly endosome membraneCell projection, axonCell projection, dendritePostsynaptic densityCytoplasm, cytosolEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Menkes disease

An X-linked recessive disorder of copper metabolism characterized by generalized copper deficiency. MNKD results in progressive neurodegeneration and connective-tissue disturbances: focal cerebral and cerebellar degeneration, early growth retardation, peculiar hair, hypopigmentation, cutis laxa, vascular complications and death in early childhood. The clinical features result from the dysfunction of several copper-dependent enzymes. A mild form of the disease has been described, in which cerebellar ataxia and moderate developmental delay predominate.

OUTRAS DOENÇAS (4)
occipital horn syndromeX-linked distal spinal muscular atrophy type 3Menkes diseaseHirschsprung disease
HGNC:869UniProt:Q04656
SCO2Cytochrome c oxidase assembly factor SCO2Candidate gene tested inDesconhecido
FUNÇÃO

Copper metallochaperone essential for the synthesis and maturation of cytochrome c oxidase subunit II (MT-CO2/COX2); together with SCO1, facilitates the incorporation of copper into the Cu(A) site of MT-CO2/COX2 (PubMed:15229189, PubMed:17189203, PubMed:19336478, PubMed:35750769). Could also act as a thiol-disulfide oxidoreductase to regulate the redox state of the cysteines in SCO1 during maturation of MT-CO2/COX2 (PubMed:19336478)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
TP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 2

An autosomal recessive, severe mitochondrial disorder characterized by hypotonia, global developmental delay, hypertrophic cardiomyopathy, lactic acidosis, gliosis, and neuronal loss in basal ganglia, brainstem and spinal cord. Serum lactate is increased, and laboratory studies show decreased mitochondrial complex IV protein and activity levels in various tissues, including heart and skeletal muscle. Most patients die in infancy of cardiorespiratory failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
32.4 TPM
Pulmão
32.3 TPM
Fibroblastos
29.5 TPM
Esôfago - Mucosa
28.2 TPM
Fallopian Tube
28.1 TPM
OUTRAS DOENÇAS (5)
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1myopia 6autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defectfatal infantile encephalocardiomyopathy
HGNC:10604UniProt:O43819
AP1B1AP-1 complex subunit beta-1Candidate gene tested inAltamente restrito
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes (PubMed:31630791). The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle, clathrin-coated vesicle membrane

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

Keratitis-ichthyosis-deafness syndrome, autosomal recessive

An autosomal recessive form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. KIDAR patients manifest ichthyosis, failure to thrive and developmental delay in childhood, thrombocytopenia, photophobia, and progressive hearing loss. Low plasma copper and ceruloplasmin levels have been reported in some patients.

OUTRAS DOENÇAS (2)
ichthyosiform erythroderma, corneal involvement, and hearing lossMEDNIK syndrome
HGNC:554UniProt:Q10567
ATP7BCopper-transporting ATPase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneLate endosomeGolgi apparatus membraneCytoplasmMitochondrion

VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Wilson disease

An autosomal recessive disorder of copper metabolism in which copper cannot be incorporated into ceruloplasmin in liver, and cannot be excreted from the liver into the bile. Copper accumulates in the liver and subsequently in the brain and kidney. The disease is characterized by neurologic manifestations and signs of cirrhosis.

OUTRAS DOENÇAS (1)
Wilson disease
HGNC:870UniProt:P35670

Medicamentos e terapias

CELECOXIBPhase 1

Mecanismo: Cyclooxygenase-2 inhibitor

BUPROPION HYDROCHLORIDEPhase 1

Mecanismo: Norepinephrine transporter inhibitor

BUPROPIONPhase 1

Mecanismo: Norepinephrine transporter inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

953 variantes patogênicas registradas no ClinVar.

🧬 AP1S1: NC_000007.13:g.(?_94024344)_(100860555_?)del ()
🧬 AP1S1: NC_000007.13:g.(?_100797796)_(100797818_?)del ()
🧬 AP1S1: GRCh37/hg19 7q22.1(chr7:98396469-102108193)x1 ()
🧬 AP1S1: GRCh37/hg19 7q22.1(chr7:100454649-101886704)x1 ()
🧬 AP1S1: NM_001283.5(AP1S1):c.261C>G (p.Tyr87Ter) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 13
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alteração do metabolismo do cobre

Centros de Referência SUS

21 centros habilitados pelo SUS para Alteração do metabolismo do cobre

Centros para Alteração do metabolismo do cobre

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
202 papers (10 anos)
#1

Precision Diagnosis of Wilson Disease Using a MultiGene Panel: Insights From a Prospective Cohort Study.

Neurology. Genetics2026 Apr

Wilson disease (WD) is an autosomal recessive disorder of copper metabolism. Conventional genetic diagnostics are low-throughput and may miss intronic, structural, or phenocopy variants, leading to delayed or missed diagnoses. In this study, we evaluate the utility of a custom next-generation sequencing (NGS) panel targeting the full-length ATP7B gene and 10 additional copper metabolism-related genes in patients with clinically suspected WD. We conducted a prospective cohort study of 144 individuals at our neurogenetic center. Variants identified by NGS were filtered and annotated with in silico tools and classified according to American College of Medical Genetics and Genomics guidelines. Confirmatory Sanger sequencing, multiplex ligation-dependent probe amplification, and reverse transcription PCR assays were performed as needed. Genetic confirmation of WD was achieved in 129 of 144 patients (90%), including 80 typical (Leipzig score ≥4) and 49 atypical (score <4) cases. Ten novel ATP7B variants, including deep intronic, noncanonical splice, and copy number variants, were identified using this panel. Among 15 genetically unresolved cases, 6 harbored variants in other copper metabolism-related genes but no pathogenic ATP7B variants. Notably, 1 patient with a Leipzig score of 4 had been clinically diagnosed with WD for years but was reclassified as spinocerebellar ataxia type 12 after panel testing revealed only a heterozygous CP variant and a CAG repeat expansion in PPP2R2B. Our comprehensive multigene NGS panel enables precise diagnosis of WD by detecting both classical and unconventional pathogenic variants, as well as distinguishing phenocopies. This improved diagnostic accuracy underscores the value of early genetic testing to guide timely intervention, especially in atypical or early-stage cases.

#2

Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease.

Clinical and molecular hepatology2026 Mar 04

Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism caused by ATP7B mutations. In this study, a novel gene therapy for WD was developed, and its efficacy and safety were evaluated in relevant animal models. Codon-optimized full-length or truncated ATP7B (tATP7B) genes were assembled with liver-specific mini promoters to construct an adeno-associated virus serotype 8 vector (AAV8). The expression and activity of these vectors were evaluated in HepG2 cells. AAV8-tATP7B viral particles were produced using a triple-plasmid cotransfection system under good manufacturing practice conditions. Long-term efficacy was evaluated in Atp7b-/- mice at three doses (5×10¹¹, 5×10¹², and 1×10¹³ vg/kg). Single-dose toxicity was assessed over 13 weeks in Sprague-Dawley rats and cynomolgus macaques. In HepG2 cells, the ability of the truncated ATP7B to export copper was comparable to that of the full-length protein, but the expression efficiency was greater. Alkaline gel electrophoresis confirmed its better compatibility with AAV packaging limits while maintaining genomic integrity, supporting its selection for AAV8-tATP7B production. In a 24-week study in Atp7b-/- mice, AAV8-tATP7B restored copper homeostasis and liver function in a dose-dependent manner and significantly reversed existing liver injury. Toxicity studies in Sprague‒Dawley rats and cynomolgus monkeys revealed no systemic toxicity, whereas reversible liver changes were observed in cynomolgus monkeys at high doses; thus, 6×10¹³ vg/kg was established as the maximum tolerated dose. These results establish the efficacy and safety profile of AAV8-tATP7B and provide the rationale for its clinical translation in patients with WD.

#3

Mitochondrial deficits and activation of autophagy in human iPSC-derived midbrain dopaminergic progenitors from patients with Wilson's disease.

Stem cell research2026 Apr

Wilson's disease (WD) is a disorder of copper metabolism that can cause severe neurological manifestations, including parkinsonism. This suggests that nigrostriatal dopaminergic system dysfunction may contribute to neurological WD. However, pathological changes in the central nervous system associated with WD remain poorly understood due to limited patient samples and the absence of animal models with robust neurological phenotypes. In our previous research, we established an induced pluripotent stem cell (iPSC) line from a WD patient carrying the R778L mutation. Here, we successfully differentiated iPSCs from both WD patients and healthy controls into midbrain dopaminergic progenitor cells (WD-mDAPCs and HC-mDAPCs, respectively). WD-mDAPCs exhibited cell-type-specific mitochondrial vulnerability, indicating that mitochondrial dysfunction may play an important role in WD neuropathogenesis. Furthermore, an increased number of autophagosomes was detected in WD-mDAPCs. Thus, we have established a novel cellular model for investigating neural abnormalities in WD. Therapeutic strategies targeting mitochondrial protection and autophagy activation may alleviate copper-induced neurological impairment in WD.

#4

Comprehensive urinary proteomics using DIA and PRM for low-abundance protein profiling of Wilson disease.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences2026 Feb 01

Wilson disease (WD) is an inherited disorder of copper metabolism with early diagnostic challenges. Urinary proteomics shows promise for identifying WD-related biomarkers, but current strategies neglect the detection of low-abundance proteins critical for preclinical diagnosis. Urine samples from 53 newly diagnosed WD patients and 47 matched controls were analyzed using an optimized proteomics strategy integrating data-independent acquisition (DIA) with parallel reaction monitoring (PRM). Functional enrichment analysis, hierarchical clustering and other multidimensional analyses were employed to delve into low-abundance protein biomarkers. Recursive feature elimination (RFE) and support vector machine (SVM) were applied to identify the candidate biomarkers, and the performance of the diagnostic model was measured by the receiver operating characteristic (ROC) curve. Furthermore, the potential biomarkers were validated by ELISA in an independent validation cohort. The optimized DIA-based untargeted proteomics identified 2263 urine proteins, including 447 differentially expressed proteins (68 upregulated and 379 downregulated). After LC-PRM-MS verification, 46 new candidate biomarkers for WD were identified and 11 were included in the final model. The SVM model performed the best in classifying WD and healthy control, and the areas under the ROC curve in the training set and the test set were 0.95 and 0.94 respectively. Four proteins were validated by ELISA in an independent cohort, with expression levels consistent with the proteomics data. The proposed DIA-PRM proteomics analysis detect more low-abundance urinary proteins, and a urinary protein biomarker panel with high accuracy for non-invasive diagnosis in WD patients was identified.

#5

A cross-sectional assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.

Medicine2026 Mar 13

Wilson's disease (WD) is a rare autosomal recessive disorder of copper metabolism requiring early diagnosis to prevent severe hepatic and neurological damage, particularly in children, where diagnostic challenges are pronounced. Serum ceruloplasmin (CPN) is a critical biochemical marker, yet its diagnostic accuracy and optimal cutoff value in pediatric populations need further evaluation in specific regional contexts. This study evaluates the diagnostic performance of serum CPN in diagnosing WD among children at Damascus University Children's Hospital and determines an optimal diagnostic cutoff value for this population. A bidirectional cross-sectional study was conducted from January 2019 to December 2022 at Damascus University Children's Hospital, including 80 children diagnosed with WD (case group) and 80 children with hepatic symptoms but without WD (control group), all under 13 years. Serum CPN was measured using immunoturbidimetry. Data on demographics, clinical presentations, Kayser-Fleischer rings, CPN levels, and 24-hour urinary copper were collected. Statistical analyses included t-tests, receiver operating characteristic analysis, and multiple linear regression (Statistical Package for Social Sciences). Ethical approval and informed consent were obtained. Mean age in the WD group was 119.15 ± 30.47 months (57.5% female). Serum CPN was significantly lower in WD (9.8 ± 3.2 mg/dL) versus controls (27.6 ± 10.4 mg/dL, P < .001). Receiver operating characteristic analysis showed high diagnostic accuracy (AUC = 0.967, 95% CI: 0.945-0.988), with an optimal CPN cutoff of 15 mg/dL (sensitivity 93.8%, specificity 85.0%). Regression identified age, female sex, neurological symptoms, Kayser-Fleischer rings, and urinary copper as predictors of lower CPN. Serum CPN is a highly accurate diagnostic marker for pediatric WD, with a 15 mg/dL cutoff optimizing sensitivity and specificity. Interpretation should consider age, sex, and clinical features.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC12 artigos no totalmostrando 196

2026

A cross-sectional assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.

Medicine
2026

Relative Exchangeable Copper Confirms Wilson Disease and Supports Reclassification of the ATP7B p.Met665Ile Variant With Conflicting Pathogenicity Evidence.

American journal of medical genetics. Part A
2026

Precision Diagnosis of Wilson Disease Using a MultiGene Panel: Insights From a Prospective Cohort Study.

Neurology. Genetics
2026

Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease.

Clinical and molecular hepatology
2026

Mitochondrial deficits and activation of autophagy in human iPSC-derived midbrain dopaminergic progenitors from patients with Wilson's disease.

Stem cell research
2026

Clinical and Demographic Profile of Wilson Disease in Young Adults: A Retrospective Study at a Tertiary Care Center in Peshawar, Pakistan.

Cureus
2026

d-Penicillamine-loaded MIL-100(Fe) for precise targeted copper chelation in Wilson's disease.

RSC advances
2025

Mitochondrial dysfunction in Wilson disease: a systematic review and meta-analysis across human and animal models.

Frontiers in molecular biosciences
2026

Comprehensive urinary proteomics using DIA and PRM for low-abundance protein profiling of Wilson disease.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2025

Wilson Disease Hiding in Plain Sight: A Case Report of Psychosis and Catatonia Revealing Underlying Liver Dysfunction.

Reports (MDPI)
2026

Development of a gastrointestinal-restricted cellulose-based copper sequestrant: potential application in treating Wilson's disease.

International journal of biological macromolecules
2025

Retropseudogene insertion generated through retrotransposition in the ATP7A gene results in premature stop codons and a case of Menkes disease.

Frontiers in neurology
2025

Postinfectious Manifestation of Wilson's Disease in COVID-19 Presenting as Writer's Cramp: A Case Report.

Acta neurologica Taiwanica
2025

Altered Sleep Patterns in Wilson's Disease Including Shortened REM Latency.

Diagnostics (Basel, Switzerland)
2025

[Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
2025

The burden of Wilson's disease: Insights into clinical, psychological, and functional dimensions.

Rehabilitacion
2025

High-Calorie Diet Accelerates the Liver Tissue Degeneration and Induces Subcutaneous White-to-Brown Fat Conversion in Mice with a Single-Allele Atp7b Mutation.

The Journal of nutrition
2025

Wilson's Disease in Oman: A National Cohort Study of Clinical Spectrum, Diagnostic Delay, and Long-Term Outcomes.

Clinics and practice
2025

Clinical and Genetic Profile of Pediatric and Adult Wilson's Disease in India.

Gastro hep advances
2025

Oxidative Stress and Psychiatric Symptoms in Wilson's Disease.

International journal of molecular sciences
2025

Neuroimaging correlates of genetics in patients with Wilson's disease.

Cerebral cortex (New York, N.Y. : 1991)
2025

Case Report: Child with Menkes syndrome complicated by bladder diverticula.

Frontiers in pediatrics
2025

Hypocupraemia-related drug-refractory seizures in Wilson disease.

Practical neurology
2025

Role and mechanisms of cuproptosis in the pathogenesis of Wilson's disease (Review).

International journal of molecular medicine
2025

Acute Deep Vein Thrombosis Presents as an Early Complication of Wilson Disease.

Cureus
2025

Current Management of Neurological Wilson's Disease.

Tremor and other hyperkinetic movements (New York, N.Y.)
2025

PSYCHOLOGICAL FEATURES OF THE SUBJECTIVE PERCEPTION OF THE QUALITY OF LIFE OF PATIENTS WITH HEPATOCEREBRAL DYSTROPHY.

Georgian medical news
2025

Application of a Core Care Nursing Outcomes Classification System for Liver Transplantation Patients: A Retrospective Case Study.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
2025

Intrathecal Baclofen Therapy Improves Refractory Status Dystonicus in Neuro-hepatic Wilson's Disease: A Case Report.

NMC case report journal
2025

Practical and Multidisciplinary Review on Wilson Disease: The Portuguese Perspective.

GE Portuguese journal of gastroenterology
2025

Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine Dihydrochloride in Patients With Wilson Disease.

JGH open : an open access journal of gastroenterology and hepatology
2025

EASL-ERN Clinical Practice Guidelines on Wilson's disease.

Journal of hepatology
2025

Research Progress in Copper Homeostasis and Diseases.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
2025

[Research progresses in gene therapy for hepatolenticular degeneration].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
2025

Targeted and non-targeted proteomics to identify the urinary protein biomarkers for Wilson disease.

Clinica chimica acta; international journal of clinical chemistry
2024

Psychiatric Symptoms in Wilson's Disease-Consequence of ATP7B Gene Mutations or Just Coincidence?-Possible Causal Cascades and Molecular Pathways.

International journal of molecular sciences
2024

Amantadine-induced psychosis in Wilson disease.

The National medical journal of India
2024

[Progress in drug therapy of Wilson's disease].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
2024

Usefulness of the Leipzig Score in the Diagnosis of Wilson's Disease - A Diagnostically Challenging Case Report.

International medical case reports journal
2024

Epidemiology of Wilson disease in Germany - real-world insights from a claims data study.

Orphanet journal of rare diseases
2024

Adverse pregnancy outcomes and effect of treatment in Wilson disease during pregnancy: Systematic review and meta-analysis.

Liver international : official journal of the International Association for the Study of the Liver
2024

Wilson's Disease-Crossroads of Genetics, Inflammation and Immunity/Autoimmunity: Clinical and Molecular Issues.

International journal of molecular sciences
2024

Kidney complications of Wilson disease and its treatments: A case report and literature review.

Clinical nephrology
2024

Brain Magnetic Resonance Imaging in Wilson's Disease-Significance and Practical Aspects-A Narrative Review.

Brain sciences
2024

Neurological Deterioration in Wilson's Disease-Types, Etiology, Course, and Management.

Discovery medicine
2024

An Effort to Identify Genetic Determinants in Siblings With Wilson Disease Manifesting Striking Clinical Heterogeneity: An Exome Profiling Study of Two Indian Families.

Pediatric neurology
2024

Kayser-Fleischer rings: The pathognomonic for Wilson's disease.

Clinical case reports
2024

Bilateral optic atrophy in Wilson disease: A case report and literature review.

Clinics and research in hepatology and gastroenterology
2024

A case of Wilson's disease combined with intracranial lipoma and dysplasia of the corpus callosum with review of the literature.

BMC neurology
2024

Unfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant.

Scientific reports
2023

Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism.

Orphanet journal of rare diseases
2023

Metallothionein: a game changer in histopathological diagnosis of Wilson disease.

Histopathology
2023

Wilson Disease: A Case Report of Psychosis Preceding Parkinsonism.

The American journal of case reports
2023

Comparison of Serum Zinc in Children of Wilson Disease and Non-Wilsonian Volunteers in Bangladesh.

Mymensingh medical journal : MMJ
2023

A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B With Wilson Disease in China.

Pediatric neurology
2023

"Because it is a rare disease…it needs to be brought to attention that there are things out of the norm": a qualitative study of patient and physician experiences of Wilson disease diagnosis and management in the US.

Orphanet journal of rare diseases
2023

Medical care of patients with Wilson disease in Germany: a multidisciplinary survey among university centers.

Orphanet journal of rare diseases
2023

Blood Based Biomarkers of Central Nervous System Involvement in Wilson's Disease.

Diagnostics (Basel, Switzerland)
2023

Structures of the human Wilson disease copper transporter ATP7B.

Cell reports
2023

Wilson's Disease-Genetic Puzzles with Diagnostic Implications.

Diagnostics (Basel, Switzerland)
2023

Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson's Disease in a Taiwanese Population: An 11-Year Follow-Up Study.

Journal of movement disorders
2023

Challenges in Anesthesia in Wilson's Disease: A Systematic Review of the Existing Literature.

Cureus
2022

Construction of diagnostic prediction model for Wilson's disease.

Frontiers in surgery
2022

Wilson's disease: Food therapy out of trace elements.

Frontiers in cell and developmental biology
2022

Retinal Degeneration in Patients with Wilson's Disease: An OCT Study in Asian Indian Population.

Annals of Indian Academy of Neurology
2022

An Update on the Future of Wilson Disease Management.

The primary care companion for CNS disorders
2022

Design, Optimization and Validation of the ARMS PCR Protocol for the Rapid Diagnosis of Wilson's Disease Using a Panel of 14 Common Mutations for the European Population.

Genes
2023

Pathogenicity of Intronic and Synonymous Variants of ATP7B in Wilson Disease.

The Journal of molecular diagnostics : JMD
2022

A Case of Megaspleen With Micrographism.

Cureus
2022

Hemorrhagic colitis induced by trientine in a 51-year-old patient with Wilson's disease waiting for liver transplantation: A case report.

World journal of hepatology
2023

[Nuclear medicine diagnostics in Wilson's disease].

Der Nervenarzt
2022

The Role of Zinc in the Treatment of Wilson's Disease.

International journal of molecular sciences
2022

Copper deposition in Wilson's disease causes male fertility decline by impairing reproductive hormone release through inducing apoptosis and inhibiting ERK signal in hypothalamic-pituitary of mice.

Frontiers in endocrinology
2022

Pearls & Oy-sters: Challenges and Controversies in Wilson Disease.

Neurology
2022

Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter.

Human molecular genetics
2022

High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson's disease.

Molecular therapy. Methods &amp; clinical development
2022

Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson's disease.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2022

Rare co-occurrence of multiple sclerosis and Wilson's disease - case report.

BMC neurology
2022

Biochemical diagnosis of Wilson's disease: an update.

Advances in laboratory medicine
2022

Almost misdiagnosed Menkes disease: A case report.

Heliyon
2022

Identification of a Novel Deep Intronic Variant by Whole Genome Sequencing Combined With RNA Sequencing in a Chinese Patient With Menkes Disease.

Frontiers in genetics
2022

Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver.

The lancet. Gastroenterology &amp; hepatology
2022

Copper-histidine therapy in an infant with novel splice-site variant in the ATP7A gene of Menkes disease: the first experience in South East Asia and literature review.

BMJ case reports
2022

Wilson's disease- management and long term outcomes.

Best practice &amp; research. Clinical gastroenterology
2022

Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson's disease.

Acta neurologica Belgica
2022

Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China.

Translational neurodegeneration
2022

Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.

Acta neurologica Belgica
2021

Catatonia: A rare presentation of Wilson's disease.

Industrial psychiatry journal
2022

CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.

JHEP reports : innovation in hepatology
2021

Acute liver failure with hemolytic anemia in children with Wilson's disease: Genotype-phenotype correlations?

World journal of hepatology
2021

Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.

Molecules (Basel, Switzerland)
2021

Generation of an induced pluripotent stem cell line ICGi030-A from a Wilson's disease patient carrying a frameshift mutation p.Lys1013fs and missense mutation p.H1069Q in the ATP7B gene.

Stem cell research
2021

Immunoglobulin a nephropathy as the first clinical presentation of Wilson disease: a case report and literature review.

BMC gastroenterology
2021

Multimodal magnetic resonance imaging analysis in the characteristics of Wilson's disease: A case report and literature review.

Open life sciences
2021

Estimating the clinical prevalence of Wilson's disease in the UK.

JHEP reports : innovation in hepatology
2021

Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects.

European journal of drug metabolism and pharmacokinetics
2021

Infantile ATP7B-Related End-Stage Liver Disease: An Exceptional Wilson Disease Phenotype From Consecutive Generations.

JPGN reports
2021

Wilson's disease: update on pathogenesis, biomarkers and treatments.

Journal of neurology, neurosurgery, and psychiatry
2022

Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.

Brain : a journal of neurology
2021

NIR-II Photoacoustic Reporter for Biopsy-Free and Real-Time Assessment of Wilson's Disease.

Small (Weinheim an der Bergstrasse, Germany)
2021

Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis.

Case reports in hepatology
2021

The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease.

Journal of the Academy of Consultation-Liaison Psychiatry
2021

Neuropathological findings in a 17-month-old boy with kinky hair due to Menkes disease.

Clinical neuropathology
2021

Investigation of the Wilson gene ATP7B transcriptional start site and the effect of core promoter alterations.

Scientific reports
2021

Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
2021

Reproductive function of long-term treated patients with hepatic onset of Wilson's disease: a prospective study.

Reproductive biomedicine online
2021

Neurological features and outcomes of Wilson's disease: a single-center experience.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Hypopituitarism in Wilson's disease resolved after copper-chelating therapy.

Endocrinology, diabetes &amp; metabolism case reports
2022

Evoked Potentials in Patients With Wilson Disease.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2022

Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.

The International journal of neuroscience
2021

Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity.

Journal of gastroenterology
2021

Whole brain volume and cortical thickness abnormalities in Wilson's disease: a clinical correlation study.

Brain imaging and behavior
2020

Neuropsychiatric Atypical Manifestation in Wilson's Disease: A Case Report and Literature Review.

Cureus
2020

[Evaluating the efficacy of diet therapy with protein component modification at Wilson disease].

Voprosy pitaniia
2020

Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters.

Case reports in medicine
2021

Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease.

Current medicinal chemistry
2020

Wilson disease patient with rare heterozygous mutations in ATP7B accompanied by distinctive nocturnal enuresis: A case report.

Medicine
2020

[Acute hemolysis crisis revealed a Wilson disease].

Annales de biologie clinique
2020

Unusual neuromuscular presentation of a Wilson's disease patient with one-stage surgical correction treatment: A case report.

Journal of orthopaedic surgery (Hong Kong)
2020

Low function of natural killer cells in treated classic Menkes disease.

The Turkish journal of pediatrics
2020

Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).

Molecular genetics and metabolism reports
2020

Neck masses due to internal jugular vein phlebectasia: Frequency in Menkes disease and literature review of 85 pediatric subjects.

American journal of medical genetics. Part A
2020

ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease.

Human genetics
2020

Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers.

European journal of gastroenterology &amp; hepatology
2020

The co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysis.

Molecular genetics &amp; genomic medicine
2020

Generation of induced pluripotent stem cell lines AKOSi002-A and AKOSi003-A from symptomatic female adults with Wilson disease.

Stem cell research
2020

Effect of Liver Transplant on Neurologic Manifestations and Brain Magnetic Resonance Imaging Findings in Wilson Disease.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
2020

Sleep disorders in Wilson disease: a systematic review and meta-analysis.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2020

Wilson disease in children and adolescents.

Archives of disease in childhood
2019

[Liver transplantation in Wilson's disease patients, 1996-2017].

Orvosi hetilap
2020

Osseous Metaplasia in a Bladder Diverticulum in a Patient with Mosaic Menkes Disease.

Urology
2019

[The new aspects of clinical nutrition at Wilson disease: actuality and perspectives].

Voprosy pitaniia
2019

Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.

Human gene therapy
2019

Characterization of Fibrinogen as a Key Modulator in Patients with Wilson's Diseases with Functional Proteomic Tools.

International journal of molecular sciences
2019

Pompholyx-Like Eruptions Induced by Penicillamine in a Patient with Wilson's Disease.

Indian journal of dermatology
2019

Wilson Disease Comorbid with Hereditary Sensory Autonomic Neuropathy Type IV and Gitelman Syndrome.

Pediatric gastroenterology, hepatology &amp; nutrition
2019

Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.

Liver international : official journal of the International Association for the Study of the Liver
2019

Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease.

The Clinical biochemist. Reviews
2019

Long surviving classical Menkes disease treated with weekly intravenous copper therapy.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2019

Single Pass Albumin Dialysis and Plasma Exchange for Copper Toxicity in Acute Wilson Disease.

Case reports in nephrology and dialysis
2019

A cellular model for Wilson's disease using patient-derived induced pluripotent stem cells revealed aberrant β-catenin pathway during osteogenesis.

Biochemical and biophysical research communications
2019

[Present status of diagnosis and treatment of hepatolenticular degeneration].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
2019

Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson's Disease.

Neurology and therapy
2019

ATP7A mutations in 66 Japanese patients with Menkes disease and carrier detection: A gene analysis.

Pediatrics international : official journal of the Japan Pediatric Society
2019

Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease.

Bioscience reports
2019

Contribution of intragenic deletions to mutation spectrum in Chinese patients with Wilson's disease and possible mechanism underlying ATP7B gross deletions.

Parkinsonism &amp; related disorders
2019

Hepatic copper accumulation in a young cat with familial variations in the ATP7B gene.

Journal of veterinary internal medicine
2018

A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient.

Medicine
2018

[Wilson's disease or hepatolenticular degeneration].

Therapeutische Umschau. Revue therapeutique
2019

Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.

Gastroenterology
2018

Recovery of severe acute liver failure without transplantation in patients with Wilson disease.

Pediatric transplantation
2019

The global prevalence of Wilson disease from next-generation sequencing data.

Genetics in medicine : official journal of the American College of Medical Genetics
2018

Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.

Molecular therapy. Methods &amp; clinical development
2018

Complications of Liver Transplant in Adult Patients With the Hepatic Form of Wilson Disease.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
2018

Animal models of Wilson disease.

Journal of neurochemistry
2018

A glimpse into the regulation of the Wilson disease protein, ATP7B, sheds light on the complexity of mammalian apical trafficking pathways.

Metallomics : integrated biometal science
2018

Wilson disease: more than meets the eye.

Postgraduate medical journal
2017

Genetic analysis of 55 northern Vietnamese patients with Wilson disease: seven novel mutations in ATP7B.

Journal of genetics
2018

Pregnancy in Wilson's disease: Management and outcome.

Hepatology (Baltimore, Md.)
2017

Wilson's disease: Prospective developments towards new therapies.

World journal of gastroenterology
2017

Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging.

Neural plasticity
2017

Comparative assessment of clinical rating scales in Wilson's disease.

BMC neurology
2017

Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease.

Molecular genetics &amp; genomic medicine
2017

Pathological Fracture of Femoral Neck Leading to a Diagnosis of Wilson's Disease: A Case Report and Review of Literature.

Journal of bone metabolism
2017

Neuroimaging Changes in Menkes Disease, Part 1.

AJNR. American journal of neuroradiology
2017

Neuroimaging Changes in Menkes Disease, Part 2.

AJNR. American journal of neuroradiology
2017

Wilson disease - currently used anticopper therapy.

Handbook of clinical neurology
2017

Other organ involvement and clinical aspects of Wilson disease.

Handbook of clinical neurology
2017

Wilson's Disease in China.

Neuroscience bulletin
2016

Linkage Analysis based on Four Microsatellite Markers to Screen for Unknown Mutation in Families with Wilson Disease.

Clinical laboratory
2016

Four-year follow-up of a Wilson disease pedigree complicated with epilepsy and hypopituitarism: Case report with a literature review.

Medicine
2016

Recurrent spontaneous subserosal hematoma of ileum causing intestinal obstruction in a patient with menkes disease: A case report.

Medicine
2016

Multiple di-leucines in the ATP7A copper transporter are required for retrograde trafficking to the trans-Golgi network.

Metallomics : integrated biometal science
2016

Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report.

Psychiatria polska
2016

Neurological features and management of Wilson disease in children: an evaluation of 12 cases.

Turk pediatri arsivi
2016

Spectrum and Classification of ATP7B Variants in a Large Cohort of Chinese Patients with Wilson's Disease Guides Genetic Diagnosis.

Theranostics
2016

Subclinical neurological involvement does not develop if Wilson's disease is treated early.

Parkinsonism &amp; related disorders
2016

Clinical Use of Next-Generation Sequencing in the Diagnosis of Wilson's Disease.

Gastroenterology research and practice
2015

Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors.

Journal of clinical and translational hepatology
2015

[Wilson disease: liver form].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
2016

ATP7B Gene Mutations in Croatian Patients with Wilson Disease.

Genetic testing and molecular biomarkers
2016

Current Drug Managements of Wilson's Disease: From West to East.

Current neuropharmacology
2016

Wilson disease: Health-related quality of life and risk for depression.

Clinics and research in hepatology and gastroenterology
2016

Influence of Ogg1 repair on the genetic stability of ccc2 mutant of Saccharomyces cerevisiae chemically challenged with 4-nitroquinoline-1-oxide (4-NQO).

Mutagenesis
2015

Wilson disease with hepatic presentation in an eight-month-old boy.

World journal of gastroenterology
2015

Proteomic investigation of whole saliva in Wilson's disease.

Journal of proteomics
2015

Novel mutations of the ATP7B gene in Han Chinese families with pre-symptomatic Wilson's disease.

World journal of pediatrics : WJP
2015

Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.

Human molecular genetics
2015

Coagulation Parameters in Wilson Disease.

Journal of gastrointestinal and liver diseases : JGLD
2015

Hemolytic anemia as first presentation of Wilson's disease with uncommon ATP7B mutation.

International journal of clinical and experimental medicine
2015

Management of Bladder Diverticula in Menkes Syndrome: A Case Report and Review of the Literature.

Urology
2015

Defective roles of ATP7B missense mutations in cellular copper tolerance and copper excretion.

Molecular and cellular neurosciences
2015

Hypersomnolence in Wilson Disease.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2014

Multiple sclerosis in two patients with coexisting Wilson's disease.

Multiple sclerosis and related disorders
2015

1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.

PloS one
2015

Genetic and Clinical Analysis in a Cohort of Patients with Wilson's Disease in Southwestern China.

Archives of medical research

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alteração do metabolismo do cobre.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alteração do metabolismo do cobre

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Precision Diagnosis of Wilson Disease Using a MultiGene Panel: Insights From a Prospective Cohort Study.
    Neurology. Genetics· 2026· PMID 41788301mais citado
  2. Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease.
    Clinical and molecular hepatology· 2026· PMID 41780554mais citado
  3. Mitochondrial deficits and activation of autophagy in human iPSC-derived midbrain dopaminergic progenitors from patients with Wilson's disease.
    Stem cell research· 2026· PMID 41763036mais citado
  4. Comprehensive urinary proteomics using DIA and PRM for low-abundance protein profiling of Wilson disease.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences· 2026· PMID 41456382mais citado
  5. A cross-sectional assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.
    Medicine· 2026· PMID 41824837mais citado
  6. A cross-sectional analysis of the quality and reliability of Wilson disease videos on Bilibili, Douyin, and Kuaishou.
    Sci Rep· 2026· PMID 41935168recente
  7. Relative Exchangeable Copper Confirms Wilson Disease and Supports Reclassification of the ATP7B p.Met665Ile Variant With Conflicting Pathogenicity Evidence.
    Am J Med Genet A· 2026· PMID 41797663recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309839(Orphanet)
  2. MONDO:0017762(MONDO)
  3. GARD:21354(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q19001238(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alteração do metabolismo do cobre
Compêndio · Raras BR

Alteração do metabolismo do cobre

ORPHA:309839 · MONDO:0017762
CID-10
E83.0 · Distúrbios do metabolismo do cobre
CID-11
Medicamentos
3 registrados
MedGen
UMLS
C0012714
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades